Stock Analysis of Insmed Inc (INSM) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code INSM
Close 55.05
Change -1.93 / 3.39 %
Volume 7192.39 K
Vol Change -9148.48 K / 55.99 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of Insmed Inc
PE (TTM)

-10.49

Very Poor
Price / Book

-30.45

Very Poor
Price / Sales

24.84

Very Poor
Piotroski F Score

4.0

Indecisive
Market Cap

8180.70 M

Enterprise Value

8864.29 M

ROA (TTM)

-55.16

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

-236.74

Very Poor
Revenue

14.45 %

280815 K
Net Profit

50.28 %

-723629.00 K
Debt to Equity

-3.51

Very Poor
Altman Z Score

-1.45

Very Poor
Quick Ratio

3.75

Very Good
Cash Ratio

3.46

Very Good


Highs/Lows of Insmed Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week22.0 150.23 % 0.513 % 58.8244.5130-May-2428-May-24
Two Week24.77 122.24 % 0.486 % 58.8221.9230-May-2424-May-24
One Month24.72 122.69 % 4.80 % 58.8221.9230-May-2424-May-24
Three Month27.72 98.59 % 3.56 % 58.8221.9230-May-2424-May-24
Six Months25.02 120.02 % 15.54 % 58.8221.9230-May-2424-May-24
One year19.03 189.28 % 26.26 % 58.8218.7830-May-2414-Jun-23
Two year18.82 192.51 % 27.72 % 58.8216.0430-May-2424-Mar-23
Five year24.21 127.39 % 91.77 % 58.8212.0930-May-2417-Mar-20
Ten year13.14 318.95 % 174.36 % 58.829.0230-May-2427-Jun-16


Technical View of Insmed Inc
RSI

83.51

Mild Bearish
MACD

6.11

Mild Bullish
ADX

32.85

Bullish
Super Trend

43.62

Mild Bullish
Williams %R

-10.22

Mild Bearish
CCI

187.19

Bearish


EMA 5

48.35

Strong Bullish
EMA 15

36.71

Strong Bullish
EMA 50

29.90

Strong Bullish
EMA 100

28.33

Strong Bullish
SMA 100

28.06

Bullish
SMA 200

26.85

Whipsaw
SMA 5 / 20

47.13 / 30.77

Strong Bullish
SMA 15 / 50

32.37 / 28.14

Strong Bullish
SMA 50 / 200

28.14 / 26.85

Mild Bullish




Charts of Insmed Inc


Returns of Insmed Inc with Peers
Period / StockINSMROIVRGENASND
1 Week150.23%-5.65%-5.73%3.60%
1 Mth122.69%-4.95%-9.20%-2.41%
3 Mth98.59%-9.44%-23.15%-8.57%
6mth120.02%8.37%-5.19%34.52%
1 Year189.28%13.97%-11.21%55.34%
2 Year192.51%133.33%-9.35%59.86%
5 Years127.39%-114.61%8.37%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Insmed Inc with Peers
Ratio / StockINSMROIVRGENASND
PE-10.491.82567.91-15.24
P/B-30.453.314.28-169.62
ROA-55.16138.640.559-58.44
ROE0221.940.7540
Debt To Equity-3.510.3700.262-3.84
Revenue280815 K
14.45 % 		28011.00 K
49.33 % 		669783 K
16.44 % 		151912 K
196.85 %
Net Income-723629.00 K
50.28 % 		-1230.02 M
45.52 % 		115794 K
37.73 % 		-601987.00 K
3.22 %


Technicals of Insmed Inc with Peers
Technical / StockINSMROIVRGENASND-
ADX32.8516.7923.1929.30
CMF0.131-0.218-0.0477-0.140
MFI80.0320.7631.9359.94
RSI83.5133.9831.0852.93
MACD Abv SignalTrueFalseFalseTrue
Price Above 50 MATrueFalseFalseFalse-
Price Above 200 MATrueFalseFalseTrue-


About : Insmed Inc

Address : 700 US Highway 202/206, Bridgewater, NJ, United States, 08807
Tel : 908 977 9900
URL : https://www.insmed.com
Code : INSM, ISIN : US4576693075, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 01_Jun_2000
Employee Count : 912

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.


Note : All Data Generated at the End of Trading Hours (EOD Data)